Piper Sandler cuts Olin’s rating, price target on weaker recovery outlook

Investing.com
13 Feb

Investing.com -- Piper Sandler downgraded Olin Corporation (NYSE:OLN) to "Neutral" from "Overweight" and lowered its price target to $33 from $41, citing a shallower-than-expected earnings recovery due to persistent economic challenges in Europe and Asia.

The firm said epoxy markets are likely to remain weak, while the recovery in Winchester earnings could be delayed as customers continue destocking through the first half of 2025. Additionally, the closure of Dow’s propylene oxide (PO) facility is expected to disrupt chloralkali markets.

Piper Sandler adjusted its model to reflect fourth-quarter and full-year 2024 earnings, 2025 guidance, and industry checks on raw material costs, construction activity, and export markets. It maintained a valuation multiple of 5.9x 2026 estimated EV/EBITDA.

The firm noted that a sluggish construction sector remains a key headwind, dampening pricing momentum across the chloralkali and vinyl chain. While Olin maintains a strong balance sheet and share repurchases could continue in 2025, the pace may slow due to lower earnings and economic uncertainty.

Piper Sandler said it sees little data supporting a volume or price recovery through most of 2025, with potential spillover into 2026, prompting the revised outlook.

Related Articles

Piper Sandler cuts Olin’s rating, price target on weaker recovery outlook

Turkey stocks higher at close of trade; BIST 100 up 1.38%

Thoma Bravo-backed SailPoint set for US market comeback after over two years

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10